Kidney International Reports
IF
4.16
Papers
4,508
Papers 4,393
1 page of 440 pages (4,393 results)
Newest
#1Sarah J. Schrauben (University of Pennsylvania)H-Index: 10
#2Eleanor Rivera (UIC: University of Illinois at Chicago)H-Index: 4
Last. Frances K. Barg (University of Pennsylvania)H-Index: 52
view all 8 authors...
Introduction null Self-management is an integral component of chronic kidney disease (CKD) treatment. Nevertheless, many patients with CKD do not adequately engage in self-management behaviors, and little is known on the underlying reasons. We aimed to identify and describe the factors that influence self-management behaviors from the perspective of adults with CKD. null null null Methods null We conducted 30 semistructured interviews with adults with CKD stage 3 or 4 from an academic nephrology...
Source
#1Allison Tong (USYD: University of Sydney)H-Index: 65
#2Nicole Evangelidis (USYD: University of Sydney)H-Index: 14
Last. Manfred Hecking (Medical University of Vienna)H-Index: 27
view all 12 authors...
Abstract null null Introduction null Globally, there are more women with chronic kidney disease (CKD), yet they comprise only 40% of patients receiving kidney replacement therapy by dialysis. We aimed to describe the perspectives of nephrologists on gender disparities in access to care and outcomes in CKD and dialysis. null null null Methods null We conducted semi-structured interviews with 51 nephrologists (28, 55% women) from 22 countries from October-2019 to April-2020. Transcripts were analy...
Source
#1Fumihiko Koiwa (Showa University)H-Index: 20
#2Shin TokunagaH-Index: 4
Last. Tadao Akizawa (Showa University)H-Index: 65
view all 6 authors...
Introduction null Evocalcet is a recently approved calcimimetic agent for secondary hyperparathyroidism (SHPT). In this study, the efficacy and safety of once-daily oral evocalcet were evaluated in patients without prior cinacalcet use (nonusers) and previously treated patients (users). null null null Methods null This post hoc analysis of a previous phase III head-to-head comparison study included SHPT patients treated with evocalcet with or without prior cinacalcet use. Endpoints included tren...
Source
Source
#1Vandana MathurH-Index: 22
#2Elizabeth LiH-Index: 4
Last. David A. BushinskyH-Index: 73
view all 3 authors...
Source
Background null Patients with cryoglobulinemic vasculitis (CV) can develop disease flare after rituximab administration. The objective of our study was to describe the prevalence, clinical characteristics, predisposing factors, and outcomes of patients with rituximab-associated flare of CV. null null null Methods null We conducted a retrospective study in a tertiary referral center until March 25, 2020. null null null Results null Among 64 patients with CV who received rituximab therapy in our c...
Source
#1Jay B. Wish (Indiana University Health)H-Index: 15
#2Stefan D. Anker (Charité - University Medicine Berlin)H-Index: 113
Last. Iain C. Macdougall (University of Cambridge)H-Index: 82
view all 6 authors...
The physiological role of iron extends well beyond hematopoiesis. Likewise, the pathophysiological effects of iron deficiency (ID) extend beyond anemia. Although inextricably interrelated, ID and anemia of chronic kidney disease (CKD) are distinct clinical entities. For more than 3 decades, however, nephrologists have focused primarily on the correction of anemia. The achievement of target hemoglobin (Hgb) concentrations is prioritized over repletion of iron stores, and iron status is generally ...
Source
#1Ellen M. CodyH-Index: 1
Last. Mark M. Mitsnefes (UC: University of Cincinnati)H-Index: 61
view all 3 authors...
Source
Source
Source
12345678910
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.